Singular Genomics Partners with Dovetail Genomics to Enable Dovetail Kits for the G4 Sequencing Platform
January 10, 2022 at 06:00 pm IST
Share
Singular Genomics Systems, Inc. announced a partnership with Dovetail Genomics to validate its proximity ligation kit
portfolio, representing the leading methods to unlock access to 3-D genome architecture, with the G4 sequencing
platform. The 3-D genome architecture at the nucleosome level is critical for understanding the regulation of gene
expression. Dovetail's best-in-class products capture this 3-D genome architecture alongside primary sequence
information using NGS. The long-range genomic information captured by Dovetail technology will enable more
comprehensive detection of structural variation and chromosome-scale phasing on the Singular Genomics platform.
Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The Company has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The Company is also engaged in developing PX, which is a development-stage multiomics platform.
SINGULAR GENOMICS SYSTEMS, INC. 
